Interactions of adrenergic compounds with brain membrane constituents.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology* / Q000648:ultrastructure; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D008566:Membranes / Q000187:drug effects; D009419:Nerve Tissue Proteins / Q000378:metabolism; D010743:Phospholipids; D051381:Rats; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*; D012995:Solubility; D013574:Synaptosomes / Q000187:drug effects / Q000201:enzymology
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D009419:Nerve Tissue Proteins; D010743:Phospholipids; D000254:Sodium-Potassium-Exchanging ATPase